Structures by: Zhang S. F.
Total: 21
C15H23NO3
C15H23NO3
Journal of medicinal chemistry (2014) 57, 16 7098-7112
a=11.012(2)Å b=11.015(2)Å c=12.183(2)Å
α=90.00° β=90.00° γ=90.00°
C15H20O3
C15H20O3
Journal of medicinal chemistry (2014) 57, 16 7098-7112
a=6.1945(19)Å b=10.289(2)Å c=21.907(5)Å
α=90° β=90° γ=90°
C100H126N4Ni2O9
C100H126N4Ni2O9
CrystEngComm (2007) 9, 1 27
a=25.531(5)Å b=25.531(5)Å c=14.907(5)Å
α=90.000(5)° β=90.000(5)° γ=120.000(5)°
C42H46CoN6O10
C42H46CoN6O10
CrystEngComm (2014) 16, 33 7701
a=12.937(8)Å b=11.150(7)Å c=17.445(8)Å
α=90.00° β=126.80(3)° γ=90.00°
C36H28CoN4O8
C36H28CoN4O8
CrystEngComm (2014) 16, 33 7701
a=9.753(6)Å b=14.101(8)Å c=14.740(8)Å
α=116.334(10)° β=108.889(10)° γ=90.034(10)°
C39H37N5O8Zn
C39H37N5O8Zn
CrystEngComm (2014) 16, 33 7701
a=18.724(7)Å b=19.302(7)Å c=20.004(8)Å
α=90.00° β=90.00° γ=90.00°
C31H33CdN5O8
C31H33CdN5O8
CrystEngComm (2014) 16, 33 7701
a=16.982(4)Å b=10.725(2)Å c=22.521(4)Å
α=90.00° β=128.552(11)° γ=90.00°
C28H30CoN4O9
C28H30CoN4O9
CrystEngComm (2014) 16, 33 7701
a=11.473(3)Å b=11.473(3)Å c=19.268(5)Å
α=90.00° β=90.00° γ=120.00°
C56H48N8O15Zn2
C56H48N8O15Zn2
CrystEngComm (2014) 16, 33 7701
a=9.779(4)Å b=13.952(6)Å c=21.144(9)Å
α=92.178(9)° β=96.238(9)° γ=109.309(8)°
C42H46CoN6O10
C42H46CoN6O10
CrystEngComm (2014) 16, 33 7701
a=12.937(8)Å b=11.150(7)Å c=17.445(8)Å
α=90.00° β=126.80(3)° γ=90.00°
C36H28CoN4O8
C36H28CoN4O8
CrystEngComm (2014) 16, 33 7701
a=9.753(6)Å b=14.101(8)Å c=14.740(8)Å
α=116.334(10)° β=108.889(10)° γ=90.034(10)°
C31H33CdN5O8
C31H33CdN5O8
CrystEngComm (2014) 16, 33 7701
a=16.982(4)Å b=10.725(2)Å c=22.521(4)Å
α=90.00° β=128.552(11)° γ=90.00°
C39H37N5O8Zn
C39H37N5O8Zn
CrystEngComm (2014) 16, 33 7701
a=18.724(7)Å b=19.302(7)Å c=20.004(8)Å
α=90.00° β=90.00° γ=90.00°
C28H30CoN4O9
C28H30CoN4O9
CrystEngComm (2014) 16, 33 7701
a=11.473(3)Å b=11.473(3)Å c=19.268(5)Å
α=90.00° β=90.00° γ=120.00°
C56H48N8O15Zn2
C56H48N8O15Zn2
CrystEngComm (2014) 16, 33 7701
a=9.779(4)Å b=13.952(6)Å c=21.144(9)Å
α=92.178(9)° β=96.238(9)° γ=109.309(8)°
C42H40N8O11Zn2
C42H40N8O11Zn2
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1382-1390
a=13.053(8)Å b=8.067(5)Å c=23.754(11)Å
α=90.00° β=117.71(2)° γ=90.00°
C49H48Cd2N8O12
C49H48Cd2N8O12
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1382-1390
a=17.811(8)Å b=19.155(8)Å c=14.683(6)Å
α=90.00° β=90.00° γ=90.00°
C61H52Co2N8O12
C61H52Co2N8O12
Dalton transactions (Cambridge, England : 2003) (2016) 45, 4 1382-1390
a=14.4417(3)Å b=23.1157(8)Å c=25.9453(10)Å
α=114.309(4)° β=100.856(3)° γ=97.740(2)°
Poly[diaquabis{μ~2~-1,4-bis[(2-methyl-1<i>H</i>-imidazol-1-yl)methyl]benzene}bis(μ~2~-glutarato)dinickel(II)] monohydrate]
C42H52N8Ni2O10,H2O
Acta Crystallographica Section C (2020) 76, 2
a=12.1880(10)Å b=15.6516(10)Å c=22.7466(19)Å
α=90° β=95.989(3)° γ=90°
Poly[[{μ~2~-1,4-bis[(2-methyl-1<i>H</i>-imidazol-1-yl)methyl]benzene}(μ~2~-glutarato)zinc(II)] tetrahydrate]
C21H24N4O4Zn,4(H2O)
Acta Crystallographica Section C (2020) 76, 2
a=9.6488(5)Å b=17.7245(12)Å c=14.9109(10)Å
α=90° β=96.470(2)° γ=90°
{μ-N,N-Bis[2-(dimethylamino)ethyl]oxamidato(2-)-\ κ^6^N,N',O':N'',N''',O}bis[(2,2'-bipyridine-κ^2^N,N')copper(II)] bis(perchlorate)
C30H36Cu2N8O22,2ClO4
Acta Crystallographica Section C (2008) 64, 3 m108-m110
a=8.6631(17)Å b=10.144(2)Å c=10.569(2)Å
α=79.73(3)° β=78.02(3)° γ=87.08(3)°